Genesys Capital Secures Second Fund Close as Sunnybrook and UHN Join University Investment Network

Genesys Capital, a Toronto-based life sciences venture capital firm, has announced the second close of its Genesys University Seed Fund, bringing additional hospital partners into the initiative.

Sunnybrook Health Sciences Centre and University Health Network (UHN) have joined the fund alongside existing partners, including the University of Toronto, McMaster University, Venture Ontario, the Temerty Group and RBC.

Fund Targets Early-Stage Canadian Life Sciences Companies

The Genesys University Seed Fund focuses on providing seed-stage investment for early-stage life sciences companies emerging from Canadian universities, hospitals and research institutes.

The initiative is designed to support businesses originating from Canada’s research and healthcare institutions, with the fund concentrating on opportunities within the life sciences sector.

Genesys Capital Brings 25 Years of Investment Experience

Genesys Capital is led by co-founder and managing director Kelly Holman.

Over the past 25 years, the firm has invested more than $400 million across biotechnology, pharmaceuticals and medical technology.

As a founding investor in the companies it backs, Genesys Capital has supported 20 exits and continues to work actively with many of the healthcare startups in its investment portfolio.